Cereal is a breakfast staple among many people. It’s a convenient meal where you choose your favorite flavor, dump it in a ...

Prism is a free, collaborative AI workspace for research. It's meant to support, not replace, human-led science. AI-enabled workspaces aim to unite disparate tools. "In 2025, AI changed software ...

OpenAI is releasing a new app called Prism today, and it hopes it does for science what coding agents like Claude Code and its own Codex platform have done for programming. Prism builds on Crixet, a ...

OpenAI launched on Tuesday a new scientific workspace program called Prism that is available for free to anyone with a ChatGPT account. Designed as an AI-enhanced word processor and research tool for ...

Scientific progress moves fast, but the way research is written and managed often doesn’t. Papers are still drafted across multiple tools, equations handled separately, citations managed elsewhere, ...

For years, artificial intelligence has promised to accelerate scientific discovery. But most AI tools still sit awkwardly on the sidelines, helping with narrow tasks like summarising papers or ...

SAN FRANCISCO – OpenAI is releasing a free tool aimed at making it easier for scientists to use ChatGPT to draft research papers and collaborate with colleagues, part of a larger effort to position ...

High-powered satellites use electromagnetic waveguides to deliver energy from one component to another. Typically, they are ...

OpenAI has introduced Prism, an all-new AI-powered workspace designed for simplifying how scientists write, collaborate and publish research. Built specifically for scientific workflows, Prism ...

Prism is a ChatGPT-powered text editor that automates much of the work involved in writing scientific papers. OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The ...

OpenAI Prism: OpenAI has introduced a new AI-powered workspace – Prism – globally. It aims to help scientists draft, revise, and collaborate on research papers, as the company seeks to reduce the ...

Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations. A phase II trial of TAS-102 in patients with colorectal cancer ...